Poolbeg Pharma PLC (AIM:POLB) Chief executive Jeremy Skillington joins Proactive London to talk about their new UK patent filings for its PredictViral diagnostic platform.
The latest applications aim to protect the method of predicting whether an individual has been exposed to a respiratory virus, the severity of the disease and whether the person is likely to be contagious.
In the meantime, the company will continue to commercialise the product, which has been designed to provide medical staff with a risk score for recently infected patients who are likely to experience a severe form of the disease.
